Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
DATA GRAPHICS | Finance

Data Bytes: RADx funding recipients

By Danielle Golovin, Staff Writer
October 8, 2020 11:52 PM UTC

NIH and BARDA granted six additional awards to COVID-19 diagnostics developers this week, bringing its total investment in the RADx Initiative for scale-up and manufacturing of new COVID-19 testing technologies to $476.4 million across 22 projects.

Launched in April, the Rapid Acceleration of Diagnostics (RADx) Initiative is a $500 million national technology development competition designed to fuel the development of rapid and easy-to-use COVID-19 tests...

Get Unlimited Access
Continue reading with a free trial.
Start a Free TrialLog In
Or Purchase This Article

BCIQ Company Profiles

Aegis Sciences Corp.

Broad Institute of Mit and Harvard

Ceres Nanosciences Inc.

Fluidigm Corp.

Ginkgo Bioworks Inc.

Helix Opco LLC

Illumina Inc.